Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSCW) Non-Current Assets (2020 - 2025)

Historic Non-Current Assets for Ensysce Biosciences (ENSCW) over the last 6 years, with Q3 2025 value amounting to $251194.0.

  • Ensysce Biosciences' Non-Current Assets fell 1462.29% to $251194.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 3328.78%. This contributed to the annual value of $252550.0 for FY2024, which is 3975.67% down from last year.
  • As of Q3 2025, Ensysce Biosciences' Non-Current Assets stood at $251194.0, which was down 1462.29% from $292860.0 recorded in Q2 2025.
  • In the past 5 years, Ensysce Biosciences' Non-Current Assets ranged from a high of $838141.0 in Q2 2021 and a low of $210883.0 during Q1 2025
  • Moreover, its 5-year median value for Non-Current Assets was $502550.0 (2023), whereas its average is $508249.3.
  • Over the last 5 years, Ensysce Biosciences' Non-Current Assets had its largest YoY gain of 1910010.18% in 2021, and its largest YoY loss of 9396.08% in 2021.
  • Ensysce Biosciences' Non-Current Assets (Quarter) stood at $754756.0 in 2021, then fell by 22.37% to $585883.0 in 2022, then fell by 28.45% to $419217.0 in 2023, then crashed by 39.76% to $252550.0 in 2024, then fell by 0.54% to $251194.0 in 2025.
  • Its Non-Current Assets was $251194.0 in Q3 2025, compared to $292860.0 in Q2 2025 and $210883.0 in Q1 2025.